St. Francis Medical Technologies Appoints David Clapper And Joseph Cutts To Its Board Of Directors
SAN FRANCISCO--(BUSINESS WIRE)--July 20, 2006--St. Francis Medical Technologies, Inc.®, the developer of the X STOP, the first FDA-approved interspinous process implant to treat Lumbar Spinal Stenosis, announced today the addition of two new members, David Clapper and Joseph Cutts, to the company's current Board of Directors. The St. Francis board has been expanded to eight members.